Advertisement Misonix Enters New Distribution Agreement With LAVI For Israel - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Misonix Enters New Distribution Agreement With LAVI For Israel

Misonix, Inc. (Misonix), a minimally invasive ultrasonic medical device company, has signed a three year distribution agreement with LAVI Industrial & Medical Agencies Ltd. (LAVI) for the distribution of the SonaStar Ultrasonic Surgical Aspirator and the BoneScalpel Ultrasonic Bone Cutter. The agreement offers LAVI with the rights to sell in Israel and includes minimum purchase requirements. LAVI, a distributor of medical devices is based in Kfar Saba, Israel.

The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. Apart from this, OsteoSculpt bone shaving technology can also be used with the SonaStar to safely remove osseous structures, hence providing access to the surgical site.

The BoneScalpel is a tissue specific osteotomy device proficient of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the potential hazards associated with rotary sharps.

“Misonix is very excited about LAVI joining our sales and distribution organization. We know LAVI as a premier distributor of advanced medical equipment in Israel,” said Michael A. McManus, Jr., president and chief executive officer of Misonix. “We are particularly pleased that they will be distributing two of our product platforms through their well established channels.”

Misonix, Inc. is a US-based company located in Farmingdale, New York.